Long non-coding RNA ATB promotes malignancy of esophageal squamous cell carcinoma by regulating miR-200b/Kindlin-2 axis.

Long non-coding RNA ATB promotes malignancy of esophageal squamous cell carcinoma by regulating miR-200b/Kindlin-2 axis.
复制标题

长链非编码RNA ATB通过调控miR-200b/Kindlin-2轴促进食管鳞癌恶变

DOI:
10.1038/cddis.2017.245
复制
发表时间:
2017-06-22
影响因子:
9
通讯作者:
Yang X
Yang X
中科院分区:
生物学1区
文献类型:
--
作者:
Li Z;Wu X;Gu L;Shen Q;Luo W;Deng C;Zhou Q;Chen X;Li Y;Lim Z;Wang X;Wang J;Yang X

文献摘要

参考文献

被引文献

相似文献

食管鳞状细胞癌(ESCC)是癌症相关死亡的主要原因之一,尤其是在中国。此外,晚期患者预后极差。然而,长链非编码RNA lnc-ATB的生物学意义及其在ESCC中的潜在作用仍有待研究。在这项研究中,我们探讨了lnc-ATB在ESCC中的作用及其促进其致癌活性的潜在机制。lnc-ATB在ESCC组织和细胞系中的表达高于正常组织和细胞系。lnc-ATB上调可作为ESCC患者的独立预后预测因子。此外,ESCC细胞的功能丧失实验表明,lnc-ATB的敲低抑制了细胞在体外和体内的增殖和迁移。机制研究表明,lnc-ATB通过调节Kindlin-2发挥致癌作用,而lnc-ATB沉默的抗迁移作用因Kindlin-2的异位表达而减弱。进一步分析表明lnc-ATB作为miR-200b和Kindlin-2的分子海绵。miR-200b/Kindlin-2信号失调介导了ESCC中lnc-ATB的致癌活性。我们的研究结果表明,lnc-ATB预测预后不良,可能作为ESCC患者的潜在治疗靶点。
Esophageal squamous cell carcinoma (ESCC) is one of the leading causes of cancer-related death, especially in China. In addition, the prognosis of late stage patients is extremely poor. However, the biological significance of the long non-coding RNA lnc-ATB and its potential role in ESCC remain to be documented. In this study, we investigated the role of lnc-ATB and the underlying mechanism promoting its oncogenic activity in ESCC. Expression of lnc-ATB was higher in ESCC tissues and cell lines than that in normal counterparts. Upregulated lnc-ATB served as an independent prognosis predictor of ESCC patients. Moreover, loss-of-function assays in ESCC cells showed that knockdown of lnc-ATB inhibited cell proliferation and migration both in vitro and in vivo. Mechanistic investigation indicated that lnc-ATB exerted oncogenic activities via regulating Kindlin-2, as the anti-migration role of lnc-ATB silence was attenuated by ectopic expression of Kindlin-2. Further analysis showed that lnc-ATB functions as a molecular sponge for miR-200b and Kindlin-2. Dysregulated miR-200b/Kindlin-2 signaling mediated the oncogenic activity of lnc-ATB in ESCC. Our results suggest that lnc-ATB predicts poor prognosis and may serve as a potential therapeutic target for ESCC patients.
DOI: 10.1016/j.tranon.2016.09.005
发表时间: 2016-12
影响因子: 5
作者:
Ren, Kewei;Li, Yahua;Lu, Huibin;Li, Zongming;Li, Zhen;Wu, Kai;Li, Zhiqin;Han, Xinwei
通讯作者: Han, Xinwei
DOI: 10.18632/oncotarget.3457
发表时间: 2015-05-10
期刊: Oncotarget
影响因子: --
作者:
Shi SJ;Wang LJ;Yu B;Li YH;Jin Y;Bai XZ
通讯作者: Bai XZ
DOI: 10.3748/wjg.14.1828
发表时间: 2008-03-28
影响因子: 4.3
作者:
Qin, Yan-Ru;Wang, Li-Dong;Guan, Xin-Yuan
通讯作者: Guan, Xin-Yuan
DOI: 10.18632/oncotarget.8257
发表时间: 2016-05-03
期刊: Oncotarget
影响因子: --
作者:
Wang W;Zhu Y;Li S;Chen X;Jiang G;Shen Z;Qiao Y;Wang L;Zheng P;Zhang Y
通讯作者: Zhang Y
DOI: 10.1007/s13277-015-3044-8
发表时间: 2015-06-01
期刊: TUMOR BIOLOGY
影响因子: --
作者:
Ren, Yuanyuan;Jin, Hongsong;Huang, He
通讯作者: Huang, He